Context sidebar

Authorised narcotics

Information

Changes to declaration of goods for the export of medicinal products (including clinical trials) and narcotics made to the Federal Office for Customs and Border Security FOCBS

Changes to the declaration of medicinal products and narcotics (17.06.2024)

Clarification by Swissmedic re. the requirements under narcotics and therapeutic products legislation pertaining to handling cannabis for medical purposes (PDF, 113 kB, 13.07.2023)

Amendment to NarcLO-FDHA from 1 March 2023 (PDF, 334 kB, 02.02.2023)On 1 March 2023, tramadol will be incorporated in List B, Annex 3 NarcLO-FDHA (SR 812.121.11).

Amendments to the narcotics ordinances on cannabis for medical purposes enter into force on 1 August 2022 (PDF, 96 kB, 11.07.2022)

Order prescription pads for narcotics (XLSX, 269 kB, 14.08.2023)

New forms for prescription of narcotics by medical professionals

The forms for prescription of narcotics by medical professionals have been amended.

Information von BAG, Swissmedic und Kantonsapothekervereinigung zu zugelassenen Arzneimitteln, die kontrollierte Substanzen des Verzeichnisses d enthalten (PDF, 28 kB, 14.02.2014)

Präzisierung von Swissmedic zum betäubungsmittelrechtlichen Status Dimethyltryptamin-haltiger Zubereitungen (PDF, 12 kB, 29.05.2013)

Permissions to operate with controlled substances

Establishment licence for handling controlled substances (Art. 2 letter h NarcCO) (XLSX, 315 kB, 20.12.2024)

Import and export of controlled substances

Forms

Permanent link of this page
www.swissmedic.ch/narcotics

Contact

Swissmedic
Division Narcotics
Hallerstrasse 7
3012 Berne
Switzerland

+41 58 466 78 50

narcotics@swissmedic.ch

News

Gesperrte Betäubungsmittel-Rezeptformulare

13.11.2017

Further links

HealthReg

Top of page